Cargando…

Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand?

Current research on cardiovascular prevention predominantly focuses on risk-stratification and management of patients with coronary artery disease (CAD) to optimize their prognosis. Several basic, translational and clinical research efforts aim to determine the etiological mechanisms underlying CAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellino, Michele, Galasso, Gennaro, Silverio, Angelo, Tedeschi, Michele, Formisano, Ciro, Romei, Stefano, Esposito, Luca, Cancro, Francesco Paolo, Vassallo, Maria Giovanna, Accarino, Giulio, Verdoia, Monica, Di Muro, Francesca Maria, Vecchione, Carmine, De Luca, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146045/ https://www.ncbi.nlm.nih.gov/pubmed/37109259 http://dx.doi.org/10.3390/jcm12082922

Ejemplares similares

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets
por: Silverio, Angelo, et al.
Publicado: (2023)

Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma
por: Esposito, Luca, et al.
Publicado: (2022)

Acute Coronary Syndrome in Patients with SARS-CoV-2 Infection: Pathophysiology and Translational Perspectives
por: Cancro, Francesco P., et al.
Publicado: (2022)

Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions
por: Bellino, Michele, et al.
Publicado: (2023)

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
por: Silverio, Angelo, et al.
Publicado: (2022)

Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients
por: Silverio, Angelo, et al.
Publicado: (2021)

COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives
por: Esposito, Luca, et al.
Publicado: (2021)

Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome
por: Di Vece, Davide, et al.
Publicado: (2021)

Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

Timing of national lockdown and mortality in COVID-19: The Italian experience
por: Silverio, Angelo, et al.
Publicado: (2020)

Abdominal Aortic Aneurysm: Natural History, Pathophysiology and Translational Perspectives
por: Accarino, Giulio, et al.
Publicado: (2022)

A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS
por: Visco, Valeria, et al.
Publicado: (2022)

Clinical outcome of patients with ST‐elevation myocardial infarction and angiographic evidence of coronary artery ectasia
por: Baldi, Cesare, et al.
Publicado: (2021)

Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low‐Flow, Low‐Gradient Aortic Stenosis
por: Ferruzzi, Germano Junior, et al.
Publicado: (2023)

Importance of Echocardiography and Clinical “Red Flags” in Guiding Genetic Screening for Fabry Disease
por: Citro, Rodolfo, et al.
Publicado: (2022)

Bioprosthetic Valve Fracture After TAVR Complicated by Balloon Rupture: Bail-Out TAVR in TAVR in SAVR
por: Attisano, Tiziana, et al.
Publicado: (2022)

Clinical conditions and echocardiographic parameters associated with mortality in COVID‐19
por: Silverio, Angelo, et al.
Publicado: (2021)

Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report
por: Attisano, Tiziana, et al.
Publicado: (2020)

Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
por: Polito, Maria Vincenza, et al.
Publicado: (2020)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2021)

Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve
por: Visco, Valeria, et al.
Publicado: (2023)

LHC Access - Where do we Stand
por: Ninin, P, et al.
Publicado: (2006)

Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19
por: Citro, Rodolfo, et al.
Publicado: (2021)

Ketogenic diet in the treatment of cancer – Where do we stand?
por: Weber, Daniela D., et al.
Publicado: (2019)

Non-Invasive Assessment of Left Ventricle Ejection Fraction: Where Do We Stand?
por: Scatteia, Alessandra, et al.
Publicado: (2021)

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
por: Moschetta, Michele, et al.
Publicado: (2020)

The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
por: Di Costanzo, Assunta, et al.
Publicado: (2023)

Where Do We Stand?
Publicado: (1891)

Cancer: Where We Stand
Publicado: (1951)

Where the College of Nursing Stands
por: Cowlin, Gertrude
Publicado: (1918)

Where Will the Empire State Stand?
Publicado: (1912)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
por: Sciarra, Antonella, et al.
Publicado: (2021)

Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021)

A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases
por: Carrizzo, Albino, et al.
Publicado: (2020)

Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art
por: Calabrese, Mariaconsiglia, et al.
Publicado: (2021)

Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?
por: Ferlazzo, Nadia, et al.
Publicado: (2016)

A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm(®)) and Anthocyanins Exerts Beneficial Cardiovascular Effects
por: Di Pietro, Paola, et al.
Publicado: (2022)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v6e0eth3tu2mcff8ddulbcup58